M-084 hydrochloride

CAS No. 51314-51-3

M-084 hydrochloride( 1H-Benzimidazol-2-amine,N-butyl-(9CI) )

Catalog No. M22250 CAS No. 51314-51-3

M-084 hydrochloride is a blocker of TRPC4/5 channel, with antidepressant and anxiolytic effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 267 Get Quote
10MG 408 Get Quote
25MG 672 Get Quote
50MG 945 Get Quote
100MG 1278 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    M-084 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    M-084 hydrochloride is a blocker of TRPC4/5 channel, with antidepressant and anxiolytic effects.
  • Description
    M-084 hydrochloride is a blocker of TRPC4/5 channel, with antidepressant and anxiolytic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1H-Benzimidazol-2-amine,N-butyl-(9CI)
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRPC4|TRPC5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    51314-51-3
  • Formula Weight
    189.26
  • Molecular Formula
    C11H15N3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (660.47 mM)
  • SMILES
    CCCCNC1=NC2=CC=CC=C2N1.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang, Fangjun, Yu, et al. Protein digestomic analysis reveals the bioactivity of deer antler velvet in simulated gastrointestinal digestion[J]. Food Research International, 2017.
molnova catalog
related products
  • SET 2

    SET 2 is an antagonist of transient receptor potential vanilloid type 2(TRPV2) with an IC50 of 0.46 μM. SET 2 shows selectivity over TRPV1, TRPV3 and TRPV4.

  • MK-2295

    MK-2295 is a potent TRPV1 antagonist. MK-2295 can be used in studies about the treatment of chronic pain.

  • Pinokalant

    Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region.